Dermata Therapeutics Correlations

DRMA Stock  USD 1.16  0.08  7.41%   
The current 90-days correlation between Dermata Therapeutics and ZyVersa Therapeutics is 0.15 (i.e., Average diversification). The correlation of Dermata Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Dermata Therapeutics Correlation With Market

Average diversification

The correlation between Dermata Therapeutics and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermata Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.

Moving together with Dermata Stock

  0.65DYN Dyne TherapeuticsPairCorr
  0.73XFOR X4 PharmaceuticalsPairCorr
  0.63JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.78MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.62PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.72INZY Inozyme PharmaPairCorr
  0.79KURA Kura OncologyPairCorr
  0.7PALI Palisade BioPairCorr
  0.72BDRX Biodexa Pharmaceticals Upward RallyPairCorr
  0.61TERN Terns PharmaceuticalsPairCorr
  0.67PPERY Bank Mandiri PerseroPairCorr

Moving against Dermata Stock

  0.66EWTX Edgewise TherapeuticsPairCorr
  0.66PRAX Praxis Precision MedPairCorr
  0.63AMLX Amylyx PharmaceuticalsPairCorr
  0.56AKRO Akero TherapeuticsPairCorr
  0.51ALVO AlvotechPairCorr
  0.39VRDN Viridian TherapeuticsPairCorr
  0.32CRNX Crinetics PharmaceuticalsPairCorr
  0.72SSNLF Samsung ElectronicsPairCorr
  0.7PTAIF PT Astra InternationalPairCorr
  0.69WMT Walmart Aggressive PushPairCorr
  0.66BAC Bank of America Fiscal Year End 10th of January 2025 PairCorr
  0.65CVX Chevron Corp Fiscal Year End 7th of February 2025 PairCorr
  0.64AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.61T ATT Inc Aggressive PushPairCorr
  0.6HPQ HP IncPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SONNZVSA
PHIOSONN
RNAZZURA
ZVSAKPRX
PHIOZVSA
PHIOKPRX
  
High negative correlations   
RNAZKPRX
RNAZSONN
RNAZZVSA
QNRXPHIO
ZURAZVSA
QNRXZVSA

Risk-Adjusted Indicators

There is a big difference between Dermata Stock performing well and Dermata Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dermata Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Dermata Therapeutics Corporate Management

Maria MBASenior AssuranceProfile
Gerald ProehlPresident, FounderProfile
Sean ProehlSenior DevelopmentProfile
David HaleCoFounder DirectorProfile
Dr MPHSenior OfficerProfile